1.1. Noncoding RNA | |
Chair: Prof. Eleonora Leucci, PhD, Katholieke Universiteit Leuven, Belgium |
|
15:00 - 15:10 | Welcome/Presentation Maite Huarte, PhD, DNA and RNA Medicine Division Director, Cima |
15:10 - 15:50 | Keynote - RNA origin of sex biased immunity Dr. Howard Chang, HMD, PhD, Standford University, USA |
15:50 - 16:15 | RNA-based mechanisms orchestrating the cell cycle and genome stability in cancer Dr. Lovorka Stojic, MSc, PhD, Barts Cancer Institute, UK |
16:15 - 16:40 | Coding and non-coding lncRNAs in Hepatocellular Carcinoma Dr. Puri Fortes, CIMA, Spain |
16:40 - 16:55 | Short talk 1 CRISPR-powered discovery of long non-coding RNA therapeutics in lung cancer Michela Coan, University College Dublin, Ireland |
16:55 - 17:10 | Short talk 2 Alteration of the M6A Regulatory genes, with the special implication of virma, is crucial for the multiple myeloma development Estíbaliz Urizar-Compains, CIMA, Spain |
Chair: Marta Montes, CIMA, Spain |
|
17:40 - 18:05 | Functions and modes of action of cis-acting long noncoding RNAs Prof. Igor Ulitsky, BSc,PhD , Weizmann Institute of Science, Israel |
18:05 - 18:30 | Eradicating drug tolerance persister cancer cells by targeting lncRNAs Prof. Eleonora Leucci, PhD,Katholieke Universiteit Leuven, Belgium |
18:30 - 18:55 | Noncoding RNA in the Coordination of DNA Replication and Genomic Stability Dr. Maite Huarte, CIMA, Spain |
18:55 - 19:10 | Short talk 3 The type 1 diabetes-associated lncRNA lncICOS-LG participates in virus-induced pancreatic cell apoptosis Leire Bergara-Mugururza, University of the Basque Country, Spain |